We next examined whether a pro-inflammatory environment characterized by the pro-inflammatory cytokines IFNγ, TNFα, and IL-1β, all associated with IBD-pathophysiology, would alter the expression of CEACAMs. Here, IL1B is linked to inflammatory bowel disease.